Sanders Chang

584 total citations
25 papers, 417 citations indexed

About

Sanders Chang is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Sanders Chang has authored 25 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Sanders Chang's work include Management of metastatic bone disease (8 papers), Palliative Care and End-of-Life Issues (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Sanders Chang is often cited by papers focused on Management of metastatic bone disease (8 papers), Palliative Care and End-of-Life Issues (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Sanders Chang collaborates with scholars based in United States, Japan and Belgium. Sanders Chang's co-authors include Kavita V. Dharmarajan, Nathan E. Goldstein, Mitsuteru Natsuizaka, Hiroshi Nakagawa, Harry Subramanian, Seiji Naganuma, Kelly A. Whelan, J. Alan Diehl, Andres J. Klein–Szanto and Shingo Kagawa and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Sanders Chang

25 papers receiving 415 citations

Peers

Sanders Chang
Megan Braunlin United States
Hande Turna Türkiye
R. E. Millikan United States
Megan Braunlin United States
Sanders Chang
Citations per year, relative to Sanders Chang Sanders Chang (= 1×) peers Megan Braunlin

Countries citing papers authored by Sanders Chang

Since Specialization
Citations

This map shows the geographic impact of Sanders Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanders Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanders Chang more than expected).

Fields of papers citing papers by Sanders Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanders Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanders Chang. The network helps show where Sanders Chang may publish in the future.

Co-authorship network of co-authors of Sanders Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Sanders Chang. A scholar is included among the top collaborators of Sanders Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanders Chang. Sanders Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsai, Chung‐Ying, Cheng-Lung Hsu, Tzong-Shyuan Tai, et al.. (2025). Asparagine deprivation enhances T cell antitumour response in patients via ROS-mediated metabolic and signal adaptations. Nature Metabolism. 7(5). 918–927. 9 indexed citations
2.
Chang, Sanders, et al.. (2022). Acute Neurological Complications of Coronavirus Disease. Neuroimaging Clinics of North America. 33(1). 57–68. 2 indexed citations
3.
Bhalla, Sheena, Huili Zhu, Jung‐Yi Lin, et al.. (2021). Impact of pathological response after neoadjuvant chemotherapy on adjuvant therapy decisions and patient outcomes in gastrointestinal cancers. Cancer Reports. 4(6). e1412–e1412. 4 indexed citations
4.
Ghiassi–Nejad, Zahra, Meng Ru, Erin Moshier, et al.. (2019). Overall Survival Trends and Clinical Characteristics of Plasmacytoma in the United States: A National Cancer Database Analysis. Clinical Lymphoma Myeloma & Leukemia. 19(5). 310–319. 11 indexed citations
5.
Salgado, Lucas Resende, Sanders Chang, Meng Ru, et al.. (2019). Utilization Patterns of Single Fraction Radiation Therapy for Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 19(5). e238–e246. 6 indexed citations
6.
Wang, Shutao, Lucas Resende Salgado, Sanders Chang, et al.. (2019). Dose Selection for Multiple Myeloma in Modern Era. Practical Radiation Oncology. 9(4). e400–e406. 4 indexed citations
7.
Sindhu, Kunal K., Sanders Chang, Jerry Liu, Richard L. Bakst, & Kavita V. Dharmarajan. (2019). In a Patient With Cancer, Not All That Enhances Is Leptomeningeal Carcinomatosis. Journal of Oncology Practice. 15(10). 558–559. 2 indexed citations
8.
Chang, Sanders, Keith Sigel, Nathan E. Goldstein, Juan P. Wisnivesky, & Kavita V. Dharmarajan. (2018). Trends of Earlier Palliative Care Consultation in Advanced Cancer Patients Receiving Palliative Radiation Therapy. Journal of Pain and Symptom Management. 56(3). 379–384. 3 indexed citations
9.
Chang, Sanders, Peter May, Nathan E. Goldstein, et al.. (2018). A Palliative Radiation Oncology Consult Service Reduces Total Costs During Hospitalization. Journal of Pain and Symptom Management. 55(6). 1452–1458. 18 indexed citations
10.
Chang, Sanders, Meng Ru, Erin Moshier, et al.. (2018). The impact of radiation treatment planning technique on unplanned hospital admissions. Advances in Radiation Oncology. 3(4). 647–654. 3 indexed citations
11.
Salgado, Lucas Resende, Shutao Wang, Sanders Chang, et al.. (2018). The Safety Profile of Concurrent Therapy for Multiple Myeloma in the Modern Era. Advances in Radiation Oncology. 4(1). 112–117. 13 indexed citations
12.
Chang, Sanders, et al.. (2018). Physician knowledge, attitudes, and practice regarding expanded carrier screening. Fertility and Sterility. 110(4). e142–e143. 1 indexed citations
13.
Chang, Sanders, Nathan E. Goldstein, & Kavita V. Dharmarajan. (2017). Managing an Older Adult with Cancer: Considerations for Radiation Oncologists. BioMed Research International. 2017. 1–13. 30 indexed citations
14.
Chang, Sanders, Peter May, Nathan E. Goldstein, et al.. (2017). A Palliative Radiation Oncology Consult Service's Impact on Care of Advanced Cancer Patients. Journal of Palliative Medicine. 21(4). 438–444. 17 indexed citations
15.
Lonardi, Sara, Takayuki Yoshino, Radka Obermannová, et al.. (2016). Exposure-response (E-R) relationship of Ramucirumab (RAM) from a global, randomized, double-blind, Phase 3 study of patients (Pts) with advanced 2nd line colorectal cancer. Annals of Oncology. 27. iv40–iv40. 1 indexed citations
16.
Chekuri, Sweta, Kian Bichoupan, Sanders Chang, et al.. (2016). Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then Plateaus. PLoS ONE. 11(7). e0159413–e0159413. 62 indexed citations
17.
Kinugasa, Hideaki, Kelly A. Whelan, Koji Tanaka, et al.. (2015). Mitochondrial SOD2 regulates epithelial–mesenchymal transition and cell populations defined by differential CD44 expression. Oncogene. 34(41). 5229–5239. 63 indexed citations
18.
Vermorken, Jan B., Lisa Licitra, Andreas Dietz, et al.. (2013). Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck. European Journal of Cancer. 49(13). 2877–2883. 23 indexed citations
19.
Natsuizaka, Mitsuteru, Seiji Naganuma, Shingo Kagawa, et al.. (2012). Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF‐1α‐mediated mRNA transcription and continuous protein synthesis. The FASEB Journal. 26(6). 2620–2630. 40 indexed citations
20.
Naganuma, Seiji, Kelly A. Whelan, Mitsuteru Natsuizaka, et al.. (2012). Notch receptor inhibition reveals the importance of cyclin D1 and Wnt signaling in invasive esophageal squamous cell carcinoma.. PubMed. 2(4). 459–75. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026